Skip to content
Home/Companies/Biotech/Curlim
Curlim

Curlim

Biotech·France·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Curlim?

Curlim is currently owned by Aquiti Gestion through AVA 1 (Aquiti Venture Amorcage) (2024 vintage), since 2024.

Hand-verified · updated 2026-04-21

Aquiti Gestion
Investor
Aquiti Gestion
AVA 1 (Aquiti Venture Amorcage) · 2024 · VC

Key facts

HQFrance
SectorBiotech
Websitecurlim.eu

More from AVA 1 (Aquiti Venture Amorcage)

Other portfolio companies in the same fund.

Boli
Boli
Active
HealthTechFrance
Prodontis
Active
HealthcareFrance
Bulq AI
Active
AI/MLFrance· 2025
Matterup
Active
ConstructionFrance· 2025
Speeral
Active
ConsumerFrance· 2025
Synboli
Active
HealthcareFrance· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Curlim

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Curlim?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Curlim.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue